文献速递脑血管病

挪威人群脑静脉血栓形成的发病率与死亡率

Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population.
PubMed 文献 · Stroke · 2020-09-04

总发病率为1.75/10万人年(95%CI 1.36-2.23),高于既往报告,30天和1年死亡率分别为3%和6%。

要点

  • CVT总发病率为1.75/10万人年,高于既往估计的0.5-1.5/10万人年。
  • 成人发病率(1.96/10万人年)高于儿童青少年(1.08/10万人年)。
  • 头痛是最常见症状(83%),30天和1年死亡率分别为3%和6%。

核心结论

  • 该挪威人群CVT发病率高于既往报告,死亡率与既往研究相似。

主要发现

  • 总发病率为1.75(95%CI 1.36-2.23)/10万人年,无显著性别差异。
  • 儿童青少年(<18岁,n=9)发病率为1.08(95%CI 0.52-1.97)/10万人年,成人(≥18岁,n=53)为1.96(95%CI 1.49-2.55)/10万人年。
  • >50岁人群发病率最高,为2.10(95%CI 1.38-3.07)/10万人年。
  • 头痛最常见(83%),其次为恶心(45%)、运动障碍(32%)和癫痫发作(32%)。
  • 横窦和颈静脉是最常见血栓部位,61%患者为多窦/静脉血栓,73%存在危险因素且多合并2个及以上危险因素。

临床怎么用

  • 在挪威人群中CVT发病率高于既往估计,临床应保持对CVT的警惕,尤其对头痛伴多窦血栓及多重危险因素者。
  • 儿童青少年和成人发病率不同,成人及>50岁人群发病率更高,诊断评估时需考虑年龄差异。
  • 尽管发病率较高,30天和1年死亡率分别为3%和6%,与既往研究相似。

局限性

  • 研究为单中心回顾性设计,仅覆盖挪威约10%人口,结果外推需谨慎。
  • 病例通过ICD-10编码和病历回顾识别,可能存在漏诊或编码偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: There are conflicting figures of the incidence of cerebral venous thrombosis (CVT). The incidence was previously estimated to around 0.5/100 000/y, but more recent studies have suggested 1 to 1.5/100 000/y. The purpose of this study was to explore the incidence and mortality of CVT in a Norwegian population. METHODS: A retrospective cross-sectional hospital population-based study conducted at Akershus University Hospital serving roughly 10% of the total Norwegian population. Patients were identified through chart reviews based on the relevant International Classification of Diseases(Tenth Revision) codes for new CVT cases in a 7-year period between January 1, 2011, and December 31, 2017. Only inhabitants living in the hospital's catchment area were included. RESULTS: Sixty-two patients aged 0 to 80 years were identified and included. The median age was 46 years and 53% were females. The overall incidence of CVT was 1.75 (95% CI, 1.36-2.23) per 100 000/y with no significant sex differences. The incidence for children and adolescents (<18 years, n=9) was lower than for adults (≥18 years, n=53); 1.08 (0.52-1.97) versus 1.96 (1.49-2.55) per 100 000/y per year, with the highest incidence for those >50 years with 2.10 (1.38-3.07)/100 000/y. Headache was the most prevalent symptom, reported in 83%, followed by nausea, motor deficits, and seizures observed in 45%, 32%, and 32% of the patients. Transverse sinuses and the jugular vein were the most frequent sites of thrombosis. In most patients (61%), thrombosis occurred in multiple sinuses/veins. Risk factors were found in 73% of the patients, and most of the patients had a combination of 2 or more risk factors. The 30-day and 1-year mortality rates were 3% and 6%. CONCLUSIONS: The incidence of CVT in this population was higher than previously reported. The mortality rate was similar to previous studies.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kristoffersen ES, Harper CE, Vetvik KG, et al. Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population. Stroke. 2020. PMID: 32883194. doi:10.1161/STROKEAHA.120.030800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。